These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31698667)

  • 1. Mathematical analysis of the Cancitis model and the role of inflammation in blood cancer progression.
    Sajid Z; Andersen M; Ottesen JT
    Math Biosci Eng; 2019 Sep; 16(6):8268-8289. PubMed ID: 31698667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global dynamics of healthy and cancer cells competing in the hematopoietic system.
    Andersen M; Hasselbalch HC; Kjær L; Skov V; Ottesen JT
    Math Biosci; 2020 Aug; 326():108372. PubMed ID: 32442449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging blood cancers and inflammation: The reduced Cancitis model.
    Ottesen JT; Pedersen RK; Sajid Z; Gudmand-Hoeyer J; Bangsgaard KO; Skov V; Kjær L; Knudsen TA; Pallisgaard N; Hasselbalch HC; Andersen M
    J Theor Biol; 2019 Mar; 465():90-108. PubMed ID: 30615883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development.
    Andersen M; Sajid Z; Pedersen RK; Gudmand-Hoeyer J; Ellervik C; Skov V; Kjær L; Pallisgaard N; Kruse TA; Thomassen M; Troelsen J; Hasselbalch HC; Ottesen JT
    PLoS One; 2017; 12(8):e0183620. PubMed ID: 28859112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell defects in Philadelphia chromosome negative chronic myeloproliferative disorders: a phenotypic and molecular puzzle?
    Bock O; Hussein K; Kreipe H
    Curr Stem Cell Res Ther; 2007 Sep; 2(3):253-63. PubMed ID: 18220909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the role of inflammation in the selection of JAK2 mutant cells in myeloproliferative neoplasms.
    Zhang J; Fleischman AG; Wodarz D; Komarova NL
    J Theor Biol; 2017 Jul; 425():43-52. PubMed ID: 28501635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive dynamics of hematopoietic stem cells and their supporting stroma: a model and mathematical analysis.
    Nguyen TN; Clairambault J; Jaffredo T; Perthame B; Salort D
    Math Biosci Eng; 2019 May; 16(5):4818-4845. PubMed ID: 31499692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
    Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
    Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.
    Guo BB; Allcock RJ; Mirzai B; Malherbe JA; Choudry FA; Frontini M; Chuah H; Liang J; Kavanagh SE; Howman R; Ouwehand WH; Fuller KA; Erber WN
    Am J Pathol; 2017 Jul; 187(7):1512-1522. PubMed ID: 28502479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.
    Koschmieder S; Mughal TI; Hasselbalch HC; Barosi G; Valent P; Kiladjian JJ; Jeryczynski G; Gisslinger H; Jutzi JS; Pahl HL; Hehlmann R; Maria Vannucchi A; Cervantes F; Silver RT; Barbui T
    Leukemia; 2016 May; 30(5):1018-24. PubMed ID: 26854026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TET proteins in malignant hematopoiesis.
    Langemeijer SM; Aslanyan MG; Jansen JH
    Cell Cycle; 2009 Dec; 8(24):4044-8. PubMed ID: 19923888
    [No Abstract]   [Full Text] [Related]  

  • 12. Hematopoietic stem cells, progenitor cells and leukemic stem cells in adult myeloproliferative neoplasms.
    Ng AP
    Leuk Lymphoma; 2013 May; 54(5):922-33. PubMed ID: 23013358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia?
    Gamis AS; Hilden JM
    J Pediatr Hematol Oncol; 2002 Jan; 24(1):2-5. PubMed ID: 11902733
    [No Abstract]   [Full Text] [Related]  

  • 14. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.
    Benton CB; Boddu PC; DiNardo CD; Bose P; Wang F; Assi R; Pemmaraju N; Kc D; Pierce S; Patel K; Konopleva M; Ravandi F; Garcia-Manero G; Kadia TM; Cortes J; Kantarjian HM; Andreeff M; Verstovsek S
    Cancer; 2019 Jun; 125(11):1855-1866. PubMed ID: 30811597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6-type cytokines in myeloproliferative disease.
    Hawley RG
    Ann N Y Acad Sci; 1995 Jul; 762():294-307. PubMed ID: 7668533
    [No Abstract]   [Full Text] [Related]  

  • 16. Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression.
    Klein C; Zwick A; Kissel S; Forster CU; Pfeifer D; Follo M; Illert AL; Decker S; Benkler T; Pahl H; Oostendorp RA; Aumann K; Duyster J; Dierks C
    J Exp Med; 2016 Feb; 213(2):273-90. PubMed ID: 26834157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feedback mechanisms control coexistence in a stem cell model of acute myeloid leukaemia.
    Crowell HL; MacLean AL; Stumpf MP
    J Theor Biol; 2016 Jul; 401():43-53. PubMed ID: 27130539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis.
    Sánchez-Aguilera A; Arranz L; Martín-Pérez D; García-García A; Stavropoulou V; Kubovcakova L; Isern J; Martín-Salamanca S; Langa X; Skoda RC; Schwaller J; Méndez-Ferrer S
    Cell Stem Cell; 2014 Dec; 15(6):791-804. PubMed ID: 25479752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression.
    Marty C; Lacout C; Droin N; Le Couédic JP; Ribrag V; Solary E; Vainchenker W; Villeval JL; Plo I
    Leukemia; 2013 Nov; 27(11):2187-95. PubMed ID: 23558526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.